Biggest News Aggregation in the World
๐Ÿ“ฐ Chronic Refractory News

Chronic Refractory News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Chronic Refractory. Real-time updates on events, politics, business and more.

Sobi, Selecta: Phase 3 DISSOLVE Program Of SEL-212 In Chronic Refractory Gout Meets Primary Goal

Swedish Orphan Biovitrum AB or Sobi (SWTUY.PK), a specialised biopharmaceutical company, and Selecta Biosciences, Inc. (SELB) announced Tuesday positive topline results from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout.
Selecta Biosciences Selecta Imm Selecta Biosciences Inc More Such Health News Swedish Orphan Biovitrum Chronic Refractory

Chronic Refractory Cough Market - Market Insight, Epidemiology and Market Forecast - 2030

Press release content from Business Wire. The AP news staff was not involved in its creation. Chronic Refractory Cough Market - Market Insight, Epidemiology and Market Forecast - 2030 - ResearchAndMarkets.com March 11, 2021 GMT DUBLIN--(BUSINESS WIRE)--Mar 11, 2021-- This โ€˜Chronic Refractory Cough (CRC) - Market Insights, Epidemiology and Market Forecast- 2030โ€™ report delivers an in-depth understanding of the Chronic Refractory Cough (CRC), historical and forecasted epidemiology as well as ...
United States United Kingdom Laura Wood E St Office Hours Call Office Hours Call Bellus Health
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science